Shares of competitors Novo Nordisk (NVO) and Eli Lilly (LLY) are moving lower following the Viking Therapeutics study results.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VKTX:
- Viking Therapeutics Issues Regulation FD Disclosure Notice
- Viking Therapeutics call volume above normal and directionally bullish
- Viking Therapeutics rumor highlighted again by Betaville blog
- Viking Therapeutics price target raised to $35 from $30 at Stifel
- Viking Therapeutics price target raised to $38 from $32 at Truist